Clinical trial
Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors
NCT00389922 · University of California, Davis, Other · Completed
Key facts
| NCT number | NCT00389922 |
|---|---|
| Title | Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors |
| Official title | Phase I Study of Two Different Schedules of Lapatinib (GW572016) in Combination With Vinorelbine in Advanced Solid Tumors |
| Lead sponsor | University of California, Davis, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Genetic, Other |
| Interventions | lapatinib ditosylate, vinorelbine ditartrate, comparative genomic hybridization, cytogenetic analysis, gene expression analysis, mutation analysis, polymerase chain reaction, polymorphism analysis, proteomic profiling, reverse transcriptase-polymerase chain reaction and 3 more |
| Enrollment | 22 |
| Start date | Dec 1, 2005 |
| Primary completion | Apr 1, 2009 |
| Completion | Dec 1, 2011 |
| First posted | Oct 19, 2006 |
| Last update posted | Apr 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: